Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.

Pharmacists play a crucial role in managing treatment with chimeric antigen receptor T-cell therapy and bispecific antibodies, focusing on patient selection and side effects, explained Eileen Peng, ...

The findings suggest assessment of CD20 may be an important factor in determining treatment options in B-cell lymphomas.

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

CD70 expression increased cytotoxicity of CD70 CAR NK cells against osteosarcoma; however, upregulation of CD70 had no effect on cytotoxicity.

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

During a live event, Samuel M. Rubinstein, MD, discussed the efficacy and safety outcomes from the KarMMa-3 trial.

MHH haematologists successfully treat seriously ill patients with acquired haemophilia A with CAR-T cells.

Market Size and Growth: Analysis of the current market size and projections for the cancer monoclonal antibody market from 2023 to 2032. This includes data on market value and volume, as well as the ...